Sign inJoin waitlistJoin the waitlist

Katherine Weilbaecher

Co-Director of Breast Cancer Research Program · Siteman Cancer Center

Credentials: · · · ·

History

Breast Cancer Research Program · Siteman Cancer Center
2014–Present
Washington University School of Medicine
2017–Present
Washington University School of Medicine
2014–Present

Dana-Farber Cancer Institute
1994–1998
Medicine
Brigham and Women’s Hospital
1994–1998
Internal Medicine
1994–1997
Stanford University Hospital
1992–1994
Stanford University School of Medicine
1988–1992
Harvard University
1983–1987

Research

Cancer to bone: a fatal attraction
Review · Nature reviews. Cancer · 2011 · First of 3 authors · Corresponding · 1,000 citations
Long-term human hematopoiesis in the SCID-hu mouse
The Journal of Experimental Medicine · 1990 · 321 citations
Developmentally regulated rearrangement and expression of genes encoding the T cell receptor-T3 complex
Cell · 1986 · 262 citations

Deborah Veis
16 papers
AH
Angela Hirbe
13 papers · 4 as a resident
DF
David Fisher
12 papers
Foluso Ademuyiwa
12 papers
Rebecca Aft
11 papers
CM
Cynthia Ma
10 papers
Gregory Lanza
10 papers
LP
Lindsay Peterson
9 papers
Gregory Fox
8 papers · 1 as a fellow
MT
Michael Tomasson
8 papers
Ashley Frith
7 papers
Elizabeth Morgan
7 papers · 5 as a resident

Grants

Mechanism of Acid Signaling in Bone Organ Metastases on Tumor and Myeloid Cell Evolution Towards Immune Suppression and Tumor Progression
National Cancer Institute · R01
Contact PI · $1.3M · Washington University
2025–2030
Retrovirus Models of Cancer
National Cancer Institute · P01
Project lead · $2.3M · Washington University
2003–2025
Overcoming the Protective Barriers of Breast Cancer in Bone Marrow with Targeted Prodrug Nanotherapy
National Cancer Institute · R01
PI · $3.1M · Washington University
2018–2024
Next Generation Approaches to Breast Cancer Using Image Guided Drug Delivery
National Cancer Institute · R01
PI · $2.4M · Washington University
2011–2017

Clinical trials

A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients
Principal investigator · Terminated · Phase 2
Washington University School of Medicine
2006–2009
Navigation Interventions for Patients With Breast Cancer and High-risk Social Determinants of Health
Sub-investigator · Not yet recruiting
Washington University School of Medicine
2026–2028
NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer
Sub-investigator · Recruiting · Phase 2
Washington University School of Medicine
2024–2027
Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing
Sub-investigator · Recruiting
Washington University School of Medicine
2022–2030